Cerebellar Metaplasticity in the Swallowing Motor System

NCT ID: NCT06721533

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-12-20

Study Completion Date

2025-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dysphagia is common and leads to significant morbidity and mortality within healthcare settings. Current approaches to dysphagia management involve altering the consistency of food and fluids. However, these approaches are not supported by a robust evidence base. Repetitive transcranial magnetic stimulation (rTMS) offers a non-invasive way to manipulate neuroelectric activity within the brain. Within the swallowing motor system, rTMS at a frequency of 5Hertz (Hz) and above is excitatory while 1Hz is suppressive.

Cortical rTMS targeting pharyngeal motor areas can alter brain activity and swallowing behaviour in healthy participants and has been shown to improve post-stroke dysphagia (PSD). Despite this, it has a small seizure risk. Cerebellar rTMS is a newer and safer technique which is more easily targeted and is effective at altering swallowing related brain activity and behaviour. Recent studies have also shown it can improve PSD.

Critically, individual responsiveness to rTMS is variable, potentially reducing its effectiveness. Metaplasticity whereby the brain is preconditioned with a neuroelectric stimulus before the treating stimulus is administered is a potential way of reducing variability. Metaplasticity has recently been shown to improve responses within the swallowing motor system following cortical rTMS. However, to date no cerebellar rTMS study has applied this approach. This is a gap in our understanding which will need to be addressed.

The overarching aim of the study is to develop a less variable and more effective treatment for neurogenic dysphagia. More specifically the study objectives are to establish:

1. Whether 10Hz Cer-rTMS delivered over hemispheric pharyngeal areas can induce SMS metaplastic changes in healthy participants.
2. If a cerebellar rTMS metaplastic stimulation protocol can affect swallowing behaviour.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Swallowing Dysphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1

1\. Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere immediately followed by 1 Hz cerebellar rTMS (600 pulses) to the same area. Pharyngeal motor evoked potential (PMEP) amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 2

2\. Sham 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere immediately followed by 1 Hz cerebellar rTMS (600 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 3

3\. Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere followed after 45 minutes by 1 Hz cerebellar rTMS (600 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 4

4\. Real 10 Hz cerebellar rTMS (250 pulses) to the right cerebellar hemisphere followed after 90 minutes by 1 Hz cerebellar rTMS (600 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 5

5\. Real 1 Hz cerebellar rTMS (600 pulses) to the right cerebellar hemisphere immediately followed by 10 Hz cerebellar rTMS (250 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 6

6\. Sham 1 Hz cerebellar rTMS (600 pulses) to the right cerebellar hemisphere immediately followed by 10 Hz cerebellar rTMS (250 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 7

7\. Real 1 Hz cerebellar rTMS (600 pulses) to the right cerebellar hemisphere followed after 30 minutes by 10 Hz cerebellar rTMS (250 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 8

8\. Real 1 Hz cerebellar rTMS (600 pulses) to the right cerebellar hemisphere followed after 60 minutes by 10 Hz cerebellar rTMS (250 pulses) to the same area. PMEP amplitude measured

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 9

Most excitatory metaplastic protocol (comparing effects of arms 1-8 against one another) to right cerebellar hemisphere. Swallowing accuracy measurements.

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Arm 10

Single dose cerebellar rTMS to right hemisphere. Swallowing accuracy measurements.

Group Type EXPERIMENTAL

Cerebellar rTMS

Intervention Type DEVICE

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cerebellar rTMS

Cerebellar rTMS applied to pharyngeal area of right hemisphere

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Healthy participants \> 18 years of age

Exclusion Criteria

1. Epilepsy
2. Cardiac pacemaker
3. Previous brain surgery
4. Previous swallowing problems
5. The use of medication which acts on the central nervous system
6. Any implanted metal in the head
7. Pregnancy (self-declared)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Manchester

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ayodele Sasegbon

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayodele Sasegbon

Role: PRINCIPAL_INVESTIGATOR

University of Manchester

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayodele Sasegbon

Role: CONTACT

Phone: 0161 789 7373

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

341596

Identifier Type: -

Identifier Source: org_study_id